Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6 | -$78 | -$108 | -$181 |
| Dep. & Amort. | $19 | $12 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $32 | $45 | $32 | $31 |
| Change in WC | $5 | -$6 | -$7 | -$22 |
| Other Non-Cash | -$18 | -$7 | $0 | $11 |
| Operating Cash Flow | $44 | -$33 | -$80 | -$158 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | -$1 |
| Inv. Purchases | -$546 | -$524 | -$524 | -$439 |
| Inv. Sales/Matur. | $585 | $529 | $464 | $354 |
| Other Inv. Act. | -$0 | -$12 | -$1 | -$17 |
| Investing Cash Flow | $39 | -$7 | -$61 | -$104 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$12 | -$10 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $197 |
| Stock Repurch. | -$40 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $5 | $2 | $24 |
| Financing Cash Flow | -$49 | -$5 | $2 | $221 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $35 | -$45 | -$138 | -$40 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49 | $94 | $232 | $272 |
| End Cash | $83 | $49 | $94 | $232 |
| Free Cash Flow | $44 | -$34 | -$80 | -$159 |